29.01.2010 • News

Henkel Sees Drop in Sales and Earnings in 2009; Performance Still Better Than Expected

Henkel has announced that 2009 sales will decline by 3.5% to around €13.57 billion. The company said it expects adjusted earnings to fall to €1.91 per preferred share from €2.19 a share a year ago. However, the company concluded that the 2009 recession year has been "better than anticipated." The company has posted a strong business performance for Q4 2009, citing better-than-expected developments in their Laundry & Home Care and Adhesive Technologies business sectors. Adjusted return on sales (EBIT) further increased in the fourth quarter to 12.4%. The company is scheduled to release final figures on Feb. 25

Company

Henkel AG & Co. KGaA

Henkelstr. 67
40589 Düsseldorf
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.